Skip to main content

Table 2 Demographic

From: Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center

Total patients 290
Age - years  
Median (range) 59 (20-88)
   < 65 years 200 (69%)
   ≥ 65 years 90 (31%)
Gender (%)  
   Male 133 (46)
   Female 157 (54)
Neurocognitive impairment (%)  
   Yes 160 (55)
   No 130 (54)
Primary tumor (%)  
   Lung (NSCLC) 126 (44)
   Breast 85 (29.5)
   Colon-rectum 24 (8.5)
   Melanoma 18 (6)
   Others 37 (12)
RPA-RTOG classes (%)  
   I 80 (27.5)
   II 148 (51)
   III 62 (21.5)
Number of BMs (%)  
   ≤ 3 180 (59)
   >3 120 (41)
Location of BMs (%)  
   Supratentorial 144 (50)
   Subtentorial 44 (15)
   Supra/Subtentorial 102 (35)
Extra-cranial disease (%)  
   Yes 278 (96)
   No 12 (4)